HCMS Podcast Episode 18
Managing HCM in Pediatric Patients: Why Early Detection Matters
Why is early detection of hypertrophic cardiomyopathy in children so critical for effective treatment? In this episode of In the Thick of It, Dr. Matthew Martinez sits down with pediatric cardiologist Dr. Tess Saarel to explore the unique challenges of managing HCM in young patients. They discuss the importance of personalized risk assessments, the role of genetics in tailoring care, and the collaborative efforts needed to improve outcomes in pediatric HCM. Join them for an insightful conversation on the evolving landscape of pediatric cardiology in HCM care.

HCMS Podcast Episode 17
Complex Layers: Screening for and Monitoring Comorbidities in HCM
What makes managing common conditions like hypertension and sleep apnea uniquely challenging in hypertrophic cardiomyopathy patients? In this episode of In the Thick of It, Dr. Michael Ayers and Dr. Robyn Bryde tackle the complexities of treating comorbidities such as obesity and type 2 diabetes within the context of HCM. They delve into how obstructive physiology impacts treatment choices and share key considerations for surgical clearance, all aimed at optimizing patient outcomes. Tune in for practical insights into managing the multifaceted health needs of HCM patients.

HCMS Podcast Episode 16.
Understanding the Impact of Atrial Fibrillation in HCM  Patients
What does it take for healthcare providers to meet the unique needs of HCM patients experiencing AFib? In this episode, Dr. Ethan Rowin and Dr. Jose Joglar delve into the critical topic of atrial fibrillation (AFib) in patients with hypertrophic cardiomyopathy (HCM). They discuss the heightened risk of stroke associated with AFib, the necessity for prompt anticoagulation, and the complexities of maintaining rhythm control. Tune in to gain pivotal insights into effective treatment strategies, including anti-arrhythmic medications and left atrial appendage closure devices, and discover the importance of comprehensive care and lifestyle management to improve outcomes for HCM patients facing AFib. 

HCMS Podcast Episode 15.
Education Patients and Families About Genetic Implications of HCM
In today’s episode of In the Thick Of It, Dr.  Anna Woo is joined by Dr. Sharon Cresci for a conversation on hypertrophic cardiomyopathy and its genetic implications. What role does genetic testing play in identifying familial variants and whether inheriting a pathogenic variant will lead to disease? Learn about the importance of genetic testing, lifelong serial screening, collaborative treatment approaches, and the processes of educating patients and families about HCM. Tune in as these experts provide insights on vigilance, follow-up care, and informed decision-making in HCM management.

HCMS Podcast Episode 14.
Surgical Considerations with Septal Myectomy and Mitral Valve Repair in HCM
Dr. Benjamin Van Boxtel welcomes Dr. Daniel Swistel and Dr. Joseph Dearani to discuss Septal Myectomy and mitral valve repair. Why is personalized patient care crucial when managing hypertrophic cardiomyopathy? Tune in as these specialists explore the importance of customized procedures, teamwork across disciplines, ongoing education, and staying abreast of the latest technological advancements in the field. Dr. Swistel and Dr. Dearani also explain the significance of comprehensive evaluations and specialist collaboration in treating HCM. But what obstacles do they encounter in their multidisciplinary efforts? Check out today's episode to discover their approaches to these challenges, and to learn how the latest surgical innovations are transforming treatment options for HCM and beyond.

HCMS Podcast Episode 13.
Optimizing Treatment: The New HCM Guidelines Explained
Dr. Matthew Martinez welcomes Dr. Steve Ommen to discuss the newly unveiled Hypertrophic Cardiomyopathy guidelines. From new medical therapies for obstructive hypertrophic cardiomyopathy, to updates regarding the recommendations for HCM patient exercise, and new insights on sudden cardiac death risk stratification, these two experts breakdown some of the crucial information contained within the new guidelines, while also highlighting the fundamental similarities and differences between previous guidelines and this newest set. But what are the actual ramifications of these new guidelines to those affected by HCM in all age groups? 

HCMS Podcast Episode 12.

Navigating Cardiac Myosin Therapy: Insights for NYHA Class II HCM Patients

When should we make the critical decision to start Cardiac Myosin therapy in NYHA Class II HCM patients? Dr. Patrycja Galazka is joined by Dr. Sara Saberi, and together they dive into the intricate world of Cardiac Myosin Inhibitors, addressing this vital question. In the ever-changing landscape of HCM management, this episode offers a beacon of clarity. Whether you're a healthcare professional dedicated to improving patient outcomes or someone personally navigating the challenges of HCM, our conversation provides essential insights. Join us for a discussion that could reshape your approach to HCM care. 

HCMS Podcast Episode 11.

Gene Therapy and Future of Heart Health with Dr. Day & Dr. Ho

How do you envision the role of gene therapy in shaping the future of cardiac care? In today’s episode, Dr. Sharlene Day engages in an enlightening conversation with Dr. Carolyn Ho, delving into the transformative world of gene therapy. Together, they navigate the complexities of gene therapy's fundamental concepts and potential applications in treating genetic cardiomyopathies and arrhythmia syndromes. Remember, understanding the potential of gene therapy is just the beginning. Collectively, we can pave the way for transformative advancements in treating genetic heart conditions by staying informed and engaged. 

HCMS Podcast Episode 10.

Advances in Nonobstructive HCM with Dr. Lyle and Dr. Kittleson 

Are the symptoms of nonobstructive hypertrophic cardiomyopathy (nHCM) holding patients back from living their fullest lives? Join Dr. Melissa Lyle and Dr. Michelle Kittleson as they unravel the mysteries of nHCM symptoms like congestion, angina, and exercise intolerance. How can we better manage these symptoms and pave the way for improved quality of life? Tune in as they explore innovative solutions, from advanced therapies to cutting-edge gene editing technologies like CRISPR, in the quest for better patient outcomes. Let's uncover the path to empowerment for nHCM patients together. 

HCMS Podcast Episode 9.

Dr. Coats& Dr. Moon on Imaging in HCM 
Cardiologist Dr. Caroline Coats is talking with with Dr. James Moon, the CEO of Mycardium AI Ltd, and a distinguished Professor of Cardiology at University College London. Dr. Moon’s groundbreaking work in cardiac MRI, especially in hypertrophic cardiomyopathy, has changed the way professionals understand and diagnose heart conditions. Today, we’re delving into his wealth of knowledge and experience on imaging in HCM.

HCMS Podcast Episode 8.

Dr. Ayers & Dr. Owens on Myosin Inhibitors 

Our topic of discussion today with Dr. Ayers and Dr. Owens is a critical one that impacts the world of cardiology and beyond cardiac myosin inhibitors. This cutting-edge area of research has the potential to revolutionize the way we approach cardiac diseases, and our experts are here to shed light on the latest developments, breakthroughs, and implications for patients and athletes alike. 

HCMS Podcast Episode 7.

2023 HCMS Sessions Oral Abstract Presentations 

Dr. Robyn Bryde and Dr. Bradley Lander interview each presenting author of the selected abstracts to tell us more about their HCM research.  These abstract presentations were selected to encore at the 2023 HCMS Scientific Sessions on October 6: 

Predictors of appropriate ICD discharges and the additive role of late gadolinium enhancement in hypertrophic cardiomyopathy - Presented by: Srekar Ravi, MD and Said Alsidawi, MD

Cumulative long-term efficacy and safety of mavacamten treatment in nonobstructive hypertrophic cardiomyopathy: updated interim analysis from the MAVERICK cohort of the MAVA-long-term extension (LTE) study up to 120 weeks - Presented by: Anjali Owens, MD

Classifying pathogenicity of TPM1 variants of unknown significance using in vitro and in silico approaches - Presented by: Stuart Campbell, MD.

HCMS Podcast Episode 6.

HCM Exercise Prescription with Dr. Michael Emery

n this episode, Cardiologist Dr. Robyn Bryde engages in an insightful conversation with Dr. Michael Emery. They delve into the crucial topic of exercise restrictions in HCM, exploring the art of crafting exercise prescriptions, counseling athletes and enthusiasts with HCM, and ensuring their safe participation in sports. Tune in for expert insights into this vital aspect of HCM management. Dr. Emery is an associate professor of medicine at the Cleveland Clinic Learner College of Medicine. He’s also the Co-Director of the sports cardiology center at Cleveland Clinic and has a background in exercise physiology.

HCMS Podcast Episode 5.

What's Next for Non-obstructive Hypertrophic Cardiomyopathy

Host Dr. Eli Friedman chats with Dr. Ahmad Masri, of Oregan Health Sciences University Hypertrophic Cardiomyopathy Center. Dr. Friedman and Dr. Masri are good friends and former coworkers, and today they’re talking about finding treatment for patients with non-obstructive Hypertrophic Cardiomyopathy, specifically focusing on drugs on clinical trials and Cardiac Mitotrope Ninerafaxstat. Join us in this gripping episode as we dive into the world of non-obstructive Hypertrophic Cardiomyopathy with two experts who are on a mission to unravel its mysteries. Dr. Friedman and Dr. Masri share their insights on groundbreaking clinical trials and the potential game-changer, Cardiac Mitotrope Ninerafaxstats. Together, we'll explore the challenges, the breakthroughs, and how science is paving the way for a brighter future in cardiac care! 

HCMS Podcast Episode 4.
HCM Care Evolution 

Dr. Bradley Lander chats with Lisa Salberg, the founder of the HCMA, the Hypertrophic Cardiomyopathy Association. Since 1996, Lisa has been on a journey to educate, advocate, and support other patients based on her experience with HCM. By tuning in, you'll unwrap how HCM centers of excellence strive to provide holistic patient care, optimize treatment strategies, and incorporate mental health support, ultimately aiming to enhance the quality of life for those living with this complex genetic heart condition.

HCMS Podcast Episode 3.
Athletes with HCM: Breakthrough Study for Vigorous Exercise

Cardiologist Dr. Robyn Bryde interviews Dr. Matthew Martinez, the Director of Sports Cardiology and Hypertrophic Cardiomyopathy at Morristown Medical Center in New Jersey. Recorded from the Care of the Athletic Heart Conference, they discuss the effects of vigorous exercise on patients with hypertrophic cardiomyopathy (HCM). Historically, patients with HCM were advised to restrict exercise, but recent studies suggest that exercise may not worsen the condition. Dr. Martinez presents findings from a groundbreaking study involving 76 elite athletes with HCM, highlighting the importance of shared decision-making and expert consultation in developing exercise plans for these patients.

HCMS Podcast Episode 2.
Outcomes of Septal Reduction Therapies in Patients with HCM

Professor of medicine and director of the HCM Center at Westchester Medical Center in New York, Dr. Srihari Naidu, speaks with Haslam Family Endowed Chair in Cardiovascular Medicine, Dr. Milind Desai. Dr. Desai discusses his article published in the Journal of the American College of Cardiology, which looks at the long-term outcomes of septal reduction therapies in Medicare patients with obstructive hypertrophic cardiomyopathy.